- Home
- LZB vs BHVN Comparison
LZB vs BHVN Comparison
Compare LZB & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZB
- BHVN
- Stock Information
- Founded
- LZB 1927
- BHVN 2013
- Country
- LZB United States
- BHVN United States
- Employees
- LZB N/A
- BHVN N/A
- Industry
- LZB Home Furnishings
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- LZB Consumer Discretionary
- BHVN Health Care
- Exchange
- LZB Nasdaq
- BHVN Nasdaq
- Market Cap
- LZB 1.6B
- BHVN 1.9B
- IPO Year
- LZB N/A
- BHVN 2017
- Fundamental
- Price
- LZB $39.35
- BHVN $14.01
- Analyst Decision
- LZB Buy
- BHVN Strong Buy
- Analyst Count
- LZB 2
- BHVN 14
- Target Price
- LZB $46.00
- BHVN $58.85
- AVG Volume (30 Days)
- LZB 589.0K
- BHVN 1.9M
- Earning Date
- LZB 08-19-2025
- BHVN 08-07-2025
- Dividend Yield
- LZB 2.20%
- BHVN N/A
- EPS Growth
- LZB N/A
- BHVN N/A
- EPS
- LZB 2.35
- BHVN N/A
- Revenue
- LZB $2,109,207,000.00
- BHVN N/A
- Revenue This Year
- LZB $3.83
- BHVN $3.00
- Revenue Next Year
- LZB $3.88
- BHVN $59.97
- P/E Ratio
- LZB $17.03
- BHVN N/A
- Revenue Growth
- LZB 3.04
- BHVN N/A
- 52 Week Low
- LZB $35.18
- BHVN $13.75
- 52 Week High
- LZB $48.31
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- LZB 49.67
- BHVN 41.34
- Support Level
- LZB $38.61
- BHVN $13.75
- Resistance Level
- LZB $41.06
- BHVN $15.09
- Average True Range (ATR)
- LZB 1.07
- BHVN 0.71
- MACD
- LZB 0.27
- BHVN 0.14
- Stochastic Oscillator
- LZB 59.29
- BHVN 20.56
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.